#biotech - Techseriesinsight

May 15, 2025
PRNewswire
Artificial Intelligence, Biotechnology

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event “Enchantment of Drug Discovery,” unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform. During the event, Dr. Yue...

April 24, 2025
PRNewswire
Biotechnology

Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep’s Tumor-Fighting Mechanism of Action

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will present new data from Cohort 1 of the GOBLET study at the 2025 American Society...

April 24, 2025
PRNewswire
Artificial Intelligence

Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic collaboration with MiBA, an innovative healthcare technology company to provide physician education...

April 23, 2025
PRNewswire
Biotechnology

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer research tools at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 at...

April 16, 2025
PRNewswire
Biotechnology

28 CAPITAL LAUNCHES NEW VENTURE TO ADVANCE SCIENTIFIC BREAKTHROUGHS FOR PATIENTS

28 Capital, a next-generation life sciences venture capital firm co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, today announced the launch of its newest platform. Focused on translating cutting-edge...

April 10, 2025
PRNewswire
Biotechnology

Rivus Pharmaceuticals Expands Leadership Team and Establishes New San Francisco Bay Area Office Ahead of Phase 2 Read-Out in MASH

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, today announced the expansion of its leadership team with the appointments of David Grainger, Ph.D.,...

April 1, 2025
PRNewswire
Biotechnology

Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with a high unmet medical need, today announced two important Board changes...

March 18, 2025
PRNewswire
Biotechnology

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational...

March 13, 2025
PRNewswire
Biotechnology

Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak

The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open for registration. Taking place from April 21-24, 2025, at the Walter E....

March 11, 2025
PRNewswire
Biotechnology

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, is highlighting its latest advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons (AAOS) 2025...